Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
StockCIK 1438533

Travere Therapeutics, Inc. (TVTX): Insider Trades and Fund Holdings

In the past 12 months, Travere Therapeutics, Inc. insiders reported 0 open-market purchases worth $0 and 17 sales worth $80.1M; 16 of the sales were reported as made under a 10b5-1 trading plan.

0Insider buys, 12 months
$0Bought by insiders, 12 months
$80.1MSold by insiders, 12 months
1Tracked funds holding

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 19, 2026.

Recent TVTX insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHoldingFiling
Oct 19Oct 15Eric M. DubeCEOCEO▼ SELL10b5-1243,73553.82$13.1M−36%Form 4 ↗
Sep 17Sep 16Eric M. DubeCEOCEO▼ SELL10b5-1195,84163.45$12.4M−31%Form 4 ↗
Sep 17Sep 16Peter HeermaEVPEVP▼ SELL10b5-1172,71763.43$11.0M−60%Form 4 ↗
Sep 17Sep 16William E. RoteChief Research OfficerChief Research Officer▼ SELL10b5-1112,85063.33$7.15M−44%Form 4 ↗
Sep 17Sep 17Eric M. DubeCEOCEO▼ SELL10b5-1108,49364.61$7.01M−20%Form 4 ↗
Sep 17Sep 15Peter HeermaEVPEVP▼ SELL10b5-1102,19062.26$6.36M−47%Form 4 ↗
Sep 17Sep 15William E. RoteChief Research OfficerChief Research Officer▼ SELL10b5-196,19862.25$5.99M−50%Form 4 ↗
Sep 17Sep 15Eric M. DubeCEOCEO▼ SELL10b5-195,66662.26$5.96M−18%Form 4 ↗
Sep 17Sep 15Christopher R. ClineCFOCFO▼ SELL10b5-150,50862.34$3.15M−37%Form 4 ↗
Sep 17Sep 15Jula InrigEVPEVP▼ SELL10b5-144,67462.34$2.79M−31%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings
All 17 TVTX insider trades →

Insiders who traded in the past year

InsiderRoleBuysBoughtSellsSoldLatest
Eric M. DubeCEO0$04$38.5MOct 19, 2026
Peter HeermaEVP0$03$17.9MSep 17, 2026
William E. RoteChief Research Officer0$02$13.1MSep 17, 2026
Christopher R. ClineCFO0$02$3.19MSep 17, 2026
Jula InrigEVP0$01$2.79MSep 17, 2026
Elizabeth E. ReedGeneral Counsel0$01$2.34MSep 17, 2026
Sandra CalvinCAO0$01$335KSep 17, 2026
Jeffrey A. MecklerDirector0$01$1.35MSep 11, 2026
ADVERTISEMENT
728 × 90 ad slot320 × 100 ad slot

Tracked funds that report TVTX

From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.

FundQuarterSharesValue% of portfolioChange
Renaissance TechnologiesQ2 20261,833,079$104.1M0.14%▼ −6.8%
Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →